Research & Publications
Dr. Lieping Chen is an immunologist interested in basic T cell biology, cancer immunology and translational research to develop innovative medicine for treating human diseases including cancer. Prior to joining Yale, he was faculty members at Johns Hopkins University School of Medicine and Mayo Clinic, and was a research scientist in Bristol-Myers Squibb/Oncogen in Seattle, Washington.
Dr. Chen has published over 370 peer-reviewed research articles. His work in discovery of the PD-1/PD-L1 pathway for cancer immunotherapy was cited as the #1 breakthrough of the years by Science magazine 2013. He is a member of the National Academy of Sciences and a fellow of the American Association for Cancer Research.
Education & Training
- PhDDrexel University, Pathology and Laboratory Medicine (1989)
- MSBeijing Union Medical College, Immunology (1986)
- MDFujian Medical College (1982)
Honors & Recognition
|Fellow||Society for Immunotherapy of Cancer||2021|
|Richard V. Smalley MD Memorial Award||Society for Immunotherapy of Cancer||2020|
|Warren Alpert Foundation Prize||Warren Alpert Foundation||2017|
|AAI-Steinman Award||American Association of Immunologists||2016|
|William B. Coley Award||Cancer Research Institute||2014|